📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma (2016)

First Author: Böhm S

Attributed to: Identifying molecular drivers and early diagnostic biomarkers in breast cancer leptomeningeal metastasis by the interrogation of cerebrospinal fluid funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-15-2657

PubMed Identifier: 27306793

Publication URI: http://europepmc.org/abstract/MED/27306793

Type: Journal Article/Review

Parent Publication: Clinical Cancer Research

Issue: 12

ISSN: 1078-0432